222 related articles for article (PubMed ID: 38064014)
21. New drugs are not enough‑drug repositioning in oncology: An update.
Armando RG; Mengual Gómez DL; Gomez DE
Int J Oncol; 2020 Mar; 56(3):651-684. PubMed ID: 32124955
[TBL] [Abstract][Full Text] [Related]
22. Repurposing psychiatric drugs as anti-cancer agents.
Huang J; Zhao D; Liu Z; Liu F
Cancer Lett; 2018 Apr; 419():257-265. PubMed ID: 29414306
[TBL] [Abstract][Full Text] [Related]
23. Phyotochemical candidates repurposing for cancer therapy and their molecular mechanisms.
Jung JH; Hwang J; Kim JH; Sim DY; Im E; Park JE; Park WY; Shim BS; Kim B; Kim SH
Semin Cancer Biol; 2021 Jan; 68():164-174. PubMed ID: 31883914
[TBL] [Abstract][Full Text] [Related]
24. Repurposing old drugs to fight multidrug resistant cancers.
Dinić J; Efferth T; García-Sosa AT; Grahovac J; Padrón JM; Pajeva I; Rizzolio F; Saponara S; Spengler G; Tsakovska I
Drug Resist Updat; 2020 Sep; 52():100713. PubMed ID: 32615525
[TBL] [Abstract][Full Text] [Related]
25. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential.
Lo YC; Senese S; France B; Gholkar AA; Damoiseaux R; Torres JZ
Sci Rep; 2017 Sep; 7(1):11261. PubMed ID: 28900159
[TBL] [Abstract][Full Text] [Related]
26. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
27. Drug repurposing for breast cancer therapy: Old weapon for new battle.
Aggarwal S; Verma SS; Aggarwal S; Gupta SC
Semin Cancer Biol; 2021 Jan; 68():8-20. PubMed ID: 31550502
[TBL] [Abstract][Full Text] [Related]
28. Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy?
Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP
Future Oncol; 2015; 11(2):181-4. PubMed ID: 25591833
[No Abstract] [Full Text] [Related]
29. Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.
Arshad U; Pertinez H; Box H; Tatham L; Rajoli RKR; Curley P; Neary M; Sharp J; Liptrott NJ; Valentijn A; David C; Rannard SP; O'Neill PM; Aljayyoussi G; Pennington SH; Ward SA; Hill A; Back DJ; Khoo SH; Bray PG; Biagini GA; Owen A
Clin Pharmacol Ther; 2020 Oct; 108(4):775-790. PubMed ID: 32438446
[TBL] [Abstract][Full Text] [Related]
30. Artificial intelligence, machine learning, and drug repurposing in cancer.
Tanoli Z; Vähä-Koskela M; Aittokallio T
Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
[No Abstract] [Full Text] [Related]
31. Can Drug Repurposing Accelerate Precision Oncology?
Schipper LJ; Zeverijn LJ; Garnett MJ; Voest EE
Cancer Discov; 2022 Jul; 12(7):1634-1641. PubMed ID: 35642948
[TBL] [Abstract][Full Text] [Related]
32. Drug Repurposing in the Development of Anticancer Agents.
Olgen S; Kotra LP
Curr Med Chem; 2019; 26(28):5410-5427. PubMed ID: 30009698
[TBL] [Abstract][Full Text] [Related]
33. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
Würth R; Thellung S; Bajetto A; Mazzanti M; Florio T; Barbieri F
Drug Discov Today; 2016 Jan; 21(1):190-199. PubMed ID: 26456577
[TBL] [Abstract][Full Text] [Related]
34. Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis.
Di Bonaventura G; Lupetti V; Di Giulio A; Muzzi M; Piccirilli A; Cariani L; Pompilio A
Microbiol Spectr; 2023 Aug; 11(4):e0035223. PubMed ID: 37306577
[TBL] [Abstract][Full Text] [Related]
35. Developing New Cancer Nanomedicines by Repurposing Old Drugs.
Yang B; Shi J
Angew Chem Int Ed Engl; 2020 Dec; 59(49):21829-21838. PubMed ID: 32270570
[TBL] [Abstract][Full Text] [Related]
36. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
Palve V; Liao Y; Remsing Rix LL; Rix U
Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
[TBL] [Abstract][Full Text] [Related]
37. The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy.
Sivapalarajah S; Krishnakumar M; Bickerstaffe H; Chan Y; Clarkson J; Hampden-Martin A; Mirza A; Tanti M; Marson A; Pirmohamed M; Mirza N
Epilepsia; 2018 Feb; 59(2):492-501. PubMed ID: 29341109
[TBL] [Abstract][Full Text] [Related]
38. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead.
Shah RR; Stonier PD
J Clin Pharm Ther; 2019 Feb; 44(1):6-22. PubMed ID: 30218625
[TBL] [Abstract][Full Text] [Related]
39. DeepDRK: a deep learning framework for drug repurposing through kernel-based multi-omics integration.
Wang Y; Yang Y; Chen S; Wang J
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33822890
[TBL] [Abstract][Full Text] [Related]
40. Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point.
Rogosnitzky M; Berkowitz E; Jadad AR
JMIR Public Health Surveill; 2020 May; 6(2):e19199. PubMed ID: 32374264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
